Cargando…
Evaluation of Schistosoma Mansoni Morbidity One Year After Praziquantel Treatment in Rhino Camp and Obongi in West Nile, Uganda
An evaluation study on reversibility of Schistosoma mansoni induced periportal fibrosis (PF) morbidity following treatment with praziquantel, 40mg/kg body weight after one year, was carried out in Rhino Camp and Obongi all are West Nile districts in northern Uganda. To assess the reversibility of Sc...
Autores principales: | Odongo-Aginya, E I, Lakwo, T L, Doehring, Med Ekkehard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
African Ethnomedicines Network
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3497850/ https://www.ncbi.nlm.nih.gov/pubmed/23878699 |
Ejemplares similares
-
Evidence of Long Term Benefit of Morbidity Reduction Due to Praziquantel Treatment Against Schistosoma Mansoni in Kigungu Fishing Village in Entebbe, Uganda
por: Odongo-Aginya, Emmanuel I, et al.
Publicado: (2011) -
The interruption of Onchocerca volvulus and Wuchereria bancrofti transmission by integrated chemotherapy in the Obongi focus, North Western Uganda
por: Luroni, Lakwo Thomson, et al.
Publicado: (2017) -
Praziquantel-encapsulated niosomes against Schistosoma mansoni with reduced sensitivity to praziquantel
por: Amer, Eglal I., et al.
Publicado: (2022) -
THE SUSCEPTIBILITY OF RECENT ISOLATES OF Schistosoma mansoni TO
PRAZIQUANTEL
por: MENDONÇA, Adriana Maria B., et al.
Publicado: (2016) -
The Role of Efflux Pumps in Schistosoma mansoni Praziquantel Resistant Phenotype
por: Pinto-Almeida, António, et al.
Publicado: (2015)